Apimeds Pharmaceuticals to effect 1-for-10 reverse stock split on March 26, 2026

Apimeds Pharmaceuticals US, Inc.

Stockholders approved 1-for-10 reverse stock split via written consent in December 2025.
Reverse split effective 12:01 a.m. ET March 26, 2026; trading begins on split-adjusted basis same day.
Every 10 pre-split shares convert to 1 share; new CUSIP 03771D201.
Company expects to file charter amendment with Delaware Secretary of State around March 25.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.